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We analyzed the incidence of vascular 
complications in adults and pediatrics live donor 
renal transplantations over 3-decades and compared 
its impact upon patient and graft survival in both 
groups. 
Material and methods: Between March 1976 and 
December 2005, 1785 live-donor renal transplants 
were performed in a single institute, of the 1546 
adults and 239 pediatric (age ≤18 years). The 
incidence of different types of vascular 
complications were determined in both groups. 
Long term patient and graft survival in patients with 
or without vascular complications and in various 
types of vascular complications were calculated & 
compared in both groups. 
Results:  The overall incidence of vascular 
complications was 2.9%, it was equally 2.9% in 
both groups. In adults, 46 complications in 45 
patients included 16 arterial, 10 renal artery 
thrombosis (0.6%), 2 cases of spasm in renal artery 
(0.1%), renal artery stenosis in 5 (0.3%), renal vein 
thrombosis in one (0.06%) and hemorrhagic 
complications in 28 patients where as there were no 
thrombotic complications in the pediatric group, 6 
case of hemorrhage (2.5%) and one case of renal 
artery stenosis (0.4%). There is steady decrease of 
vascular complications over the last 3 decades .The 
vascular complications significantly adverse patient 
and graft survival in both groups (p<0.001).  
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The 5-years patient and graft survival in adults and 
pediatrics with or without vascular complications 
were 59.5±9.2%, 89.14±0.89%, 57.5±18.7% and 
90.18±2.2% for the patient and 40.14±7.75%, 
97.79±1.14%, 28.57±17.07% and 77.18±3.02% for 
the graft. There is no statistical significant 
difference in either patient or graft survival in 
thrombotic, stenotic or hemorrhagic complications 
in adult or hemorrhagic complications in the 
pediatric group. (p=0.22 and p=0.142 respectively). 
Conclusions: There is no increase in incidence of 
vascular complications in pediatrics than adult 
transplants. The survival either graft or patient is 
comparable between adult and pediatric with or 
without vascular complications and the subgroups 




The treatment of choice for patients with end-stage 
renal disease is renal transplantation. Live-donor 
renal transplantation has better graft and patient 
survival than cadaver [1,2], because it is precious, it 
should be continuously monitored to detect and 
manage any complications. Vascular complications 
have negative impact on patient and graft survival 
[3]. The incidence of vascular complications is 
higher in cadaver than live donor transplants as live 
donor renal transplantation is performed in more 
favorable conditions.Vascular complications is 
discussed in the literature in large number of 
publications, most of them belong to the cadaver 
[4], little in live donor [3]. We analyzed the 
incidence of vascular complications in adults and 
 pediatrics live donor renal transplantations over 3-
decades and compared its impact upon patient and 
graft survival in both groups. 
 
Material and methods 
 
Between March 1976 and December 2005, a total of 
1785 live-donor renal transplants were performed in 
a single institute, they were 1546 adults and 239 
pediatrics (age ≤18 years). In the adult group the 
mean age was 32.4±8 year (range 19 to 62 years) 
whereas it was 14.12±3.38 years (range 5-18 years) 
in the pediatric group. 
 
Operative technique: The graft was revascularized 
in standard fashion. In the adult group, the main 
renal artery was anastmosed to internal iliac artery 
in 1417 patients, to external iliac artery in 105 
patients, to common iliac artery in 20 patients and 
to aorta in one patient, whereas the renal vein 
anastmosed to external iliac vein in 1515 pateints, 
common iliac in 20 patients and IVC in 9 patients. 
In the pediatric group, the renal artery was 
anastomosed to internal iliac in 159 patients, 
external iliac in 4 patients, common iliac in 65 
patients and aorta in 11 patients. The renal vein was 
anastomoed to external iliac vein in 136 patients 
common iliac in 6 while to IVC in 97 patients. 
The vascular ischemia time was 45.01±13,78 
minutes (range 18-132min) in adult group, while it 
was 48.89 ±15.49 minutes in pediatric group .Table 
1 list technical variables of vascular anastomosis in 
both groups. Several immunosuppressive regimens 
were used throughout this period (table 1).  
 
Postoperative work-up: After surgery the patients 
were monitored clinically, biochemically and 
radiologically. Different modalities were used to 
diagnose a vascular complication. When cases of 
renal artery stenosis or thrombosis were suspected 
clinically, Doppler ultra-sound, magnetic resonance 
angiography and conventional angiography were 
performed to confirm the diagnosis. Cases of 
hemorrhage were diagnosed by clinical observation, 
while haematoma was detected by gray-scale 
ultrasound and confirmed by computerized 
tomography and magnetic resonance imaging with 
or without aspiration of perigraft collections. Data 
were stored in an electronic data base. 
 
Statistical analysis: To determine the statistical 
significance of differences the Pearson and chi-
square tests were used. Survival of grafts and 
patients was calculated using the Kaplan-Meier 
technique. Differences in survival were calculated 





The over all incidence of vascular complications 
was 2.9%, it was equally 2.9% in both groups. 
There were complications in 45 adult patients 
included 17 arterial complications, 10 renal artery 
thrombosis (0.6%), 2 cases of spasm in renal artery 
(0.1%) renal artery stenosis in 5 (0.3%), renal vein 
thrombosis in one patient (0.06%) and 
haemorrhagic complications in 28 patients (1.8%) 
while in pediatric group, there was no cases of 
either renal artery or vein thrombosis, 6 cases of 
hemorrhage (2.5%) and one case of renal artery 
stenosis (0.4%). 
The incidence of vascular complications was 
correlated to various pretransplant, technical and 
post transplant variables (table 1). One uni-varaite 
analysis, the female Gender, arterial anastomosis to 
external iliac artery had higher complications in 
adult group as well as age 5-10 year in pediatric. 
ATN is statistically significant higher in both 
groups of complications than normal (p<0.001) 
The time of occurrence, main presenting symptoms 
the primary method for diagnosis, management and 
prognosis of our complications are displayed in 
table 2.        
The vascular complications significantly adverse 
patient and graft survival in both groups (p<0.001). 
The 5-years patient survival in adults and pediatrics 
with or without vascular complications were 
59.5±9.2%, 89.14±0.89%, 57.5±18.7% and 
90.18±2.2% for the patient. The 5-years graft 
survival was 40.14±7.75%, 97.79±1.14%, 
28.57±17.07% and 77.18±3.02% for the same 
groups. There is no statistical significant difference 
in either patient or graft survival in thrombotic, 
stenotic or hemorrhagic complications in adult or 
hemorrhagic complications in the pediatric group. 
(p=0.22 and p=0.142 respectively). 
The long term graft and patient survival in patients 
with or without vascular complications are 
displayed in table 3 and 4 & figures 1 and 2   
whereas the long term graft and patient survival in 
relation to various causes of vascular complications 
are displayed in tables 5 and 6 (P =0.142  & P = 















Recipient age     
5-10   37/3 (8.1)  
10-15   97/4 (4.1) 0.02 
15-18   105/-  
18-20 86/1 01.2)    
20- 648/13 (2)    
30- 520/21 (4) 0.18   
40- 248/10 (4)    
50- 44/1 (2.3)    
Recipient sex     
Male  1175/28 (2.4) 0.014 153/4 (2.6)  
Female 371/18 (4.9)  86/3 (3.5) 0.7 
Donor age     
<30 658/27 (4.1)  47/0  
30- 469/11 (2.3) 0.102 107/3 (2.8) 0.24 
40- 281/7 (2.5)  67/4 (6)  
50- 138/1 (0.7)  18/0  
Donor Sex     
Male 775/27 (3.5) 0.23 83/4 (4.8)  
Female 771/19 (2.5)  156/3 (1.9) 0.206 
HLA mismatch     
Zero match  120/2 (1.7)  3/-  
One 264/11 (4.2)  26/3 (11.5) 0.02 
Two 786/23 (2.9) 0.84 169/3 (1.8)  
Three 196/7 (3.6)  32/-  
Four 136/2 (1.5)    
 Technical 
No of renal arteries     
Single 1375/39 (2.8)  215/7 (3.3) 0.36 
Multiple 171/7(3.4) 0.89 24/-  
Main renal artery     
Int. iliac 1417/38 (2.7)  156/3(1.9)  
Extra iliac 105/8 (7.6) 0.037 4/- 0.32 
Common iliac 23/-  61/4(6.2)  
Aorta 1/-  11/-  
Ischemia time (min)     
<30 195/3 (1.5)  24/-  
30-60 1192/40 (3.4) 0.27 176/5 (2.8) 0.49 
>60 154/3 (1.9)  39/2 (5.1)  
Time to diuresis     
Immediate 1428/38(2.7)  205/5 (2.4) 0.27 
Delayed 116/8(6.9) 0.009 34/2 (5.9)  
 ATN     
No 1468/35(2.4)  224/5 92.2)  
Yes 78/11(14.1) 0.00001 15/2 913.3) 0.013 
Transplant received     
First 1478/43(2.9)  235/7 (3)  
Second 66/3(4.5) 0.72 4/- 0.72 
Third 2/-    
 Post transplant 
Acute rejection     
No 909/26 (2.9)  131/3 (2.3)  
Yes 637/20 (3.1) 0.7 107/4 (3.7) 0.51 
Immunosupp. regimens     
Steroid + Aza 
Steroid + CsA 








St+sirolimus(MMf/FK) 2/- 0.26 3/- 0.23 
Others  248/8 (3.2)  47/2 (4.2)  
Transplant are     
1976-1985 127/7 (5.5)  17/-  
1986-1995 654/18 (2.8) 0.21 92/4 (4.3) 0.51 
1996-2005  765/21 (2.7)  130/3 (2.3)  
 
Table 2. Diagnosis, management & outcome of vascular complication 
 
  


















  6 
Time of 
occurrence after 
transplantation   
Mean 2.9 ±3.1day 6 month in 3 
5 year in 1 
8 year in 1 
12 ± 11 days   7-19 
Main presenting 
symptom 
Anuria Sever persistent 
hypertension 
Blood from drains , mass 
may be shock 
  Blood from drains,   
  mass may be shock 
Primary  
diagnostic method 
  - Duppler ultrasonography 
  - Angiography 
- Duppler   
  ultrasonography 
  - Angiography 
  - Magnetic resonance   
    angiography 
- Clinical suspicion  
- Grey scale ultrasound 
- Spiral CT 
- Perigraft aspiration 
- Clinical suspicion  
- Grey scale  
   ultrasound 
- Spiral CT 
   - Perigraft aspiration 
Management  - Graft nephrectomy = 6 
- End artrectomy = 4 
- Massage of renal artery= 2 
   (kidney became vascularized) 
Improved stenosis in 
one restensosis in two  
Surgical exploration 22 
Percutanesus drainage 6 
Surgical exploration in   
all patients 
Prognosis Preservation of graft treated with  
endarterctomy or massage of  
artery 
- PTA------- 3 
- No intervention----- 2 
- (lost kidney) 
Graft nephrectomy in 5 
otherwise good 
prognosis 
 - Graft nephrectomy 
    in 3 
 - Otherwise good   
 Grognosis 
 





















Adults with vascular complications                    40.14 7.75 19.62 7.68 
Pediatrics without vascular complications                   77.18 3.02 47.11 4.36 
Adults  without vascular complications                   
 

























Adults with vascular complications                    59.5 9.2 29.09 10.84 
Pediatrics without vascular complications                   90.18 2.22 76.15 4.11 
Adults  without vascular complications   
                 

























Thrombotic complications 19.23 15.18 19.23 15.18 
Hemorrhagic complications 40.02 9.8 15.01 8.9 
Vasclar complications in pediaterics 
 
28.57 17.07 14.29 13.23 
 
 P = 0.142 
 





















Thrombotic complications 58.33 25.06 58.33 25.06 
Hemorrhagic complications 49.9 10.91 18.71 10.9 
Vasclar complications in pediaterics 
 
57.14 18.7 57.14 18.7 
  
P = 0.222 
  
 






Fig. 2.  Graft survival of patients with and without vascular 




Over the past three decades, the rate of 
complications following kidney transplantation has 
decreased due to improvements in surgical and 
diagnostic techniques, as well as to the greater 
safety of the immunosuppressive regimens. The 
incidence of vascular complications was reportedly 
as high as 30% during the early stages of 
development of the transplant procedure [5]. 
currently the incidence ranged from 0.8 to 6% [6]. 
Arterial complications are more frequent and more 
dangerous than venous misadventures.  
Several mechanisms causing vascular thrombosis 
have been addressed such as faulty suture technique 
producing incomplete intimal re-approximation 
with secondary intraluminal fibrosis, postoperative 
hypotension, hypercoagulable state, atherosclerosis 
of the donor or recipient vessels, trauma to the 
donor artery during perfusion, wide  disparity in 
vessel size, torsion of the graft during performance 
of the anastomosis, kinking of artery and angulation 
of the vein owing to improper location of the graft 
or to the anastomosis [5,7]. 
In the present series , the overall incidence of  renal 
artery  thrombosis was 0.5 % , it was 0.6 % in adult 
which is similar to our previous report [3]  while  
we were not confronted with either renal artery or 
vein thrombosis in the pediatric group ,  this may be 
explained by  meticulous vascular anastomosis by 
well-trained highly specialized urologists and our 
routine policy of one week post -transplantation 
heparinization while in the adult  the issue of 
heparinizaion is controversial, heparin was found to 
decrease thromboembolic complications without an 
impact upon lymph drainage or bleeding sequels 
[8]. Two different group of investigators showed 
that LMWH can reduce or even abolish the 
thrombotic sequels without increase in 
postoperative surgical bleeding [9,10], Humar et al., 
denied the necessity of anticoagulation for non-
risky renal transplants and advised to restrict a short 
course of heparinization only for risky patients [11].  
Recently in  our institute we finished a prospective 
randomized study included 75 patients randomized 
between three arms one group did not received any 
anticoagulants, other receive conventional 
unfractionated heparin and the third group received 
LMWH in non risky renal transplants, and we 
concluded that post-operative heparin 
administration in non-risky live donor renal 
transplantation is associated by significant drop in 
the hemoglobin level as well as prolonged and 
excessive lymph drainage without improvement in 
graft outcome and should not be a routine  in non-
risky live-donor renal transplantation [12].  
Graft renal artery stenosis occur in a range of 0.8 to 
12.4% of all renal transplants [13,14]. The stenosis 
may be located before the anastomosis (because of 
atherosclerotic disease in the donor vessel), at the 
anastomosis (secondary to vessel perfusion injury, 
faulty suture technique, or reaction to suture 
material), or after the anastomosis (due to rejection, 
turbulent flow from kidney malposition, or arterial 
twisting, kinking, or compression). Immunological 
injury is also proposed as the possible cause. 
Approximately half of renal artery stenoses occur at 
the anastomosis [15,16]. The gold standard for 
diagnosing stenosis still remains renal angiography 
[15]. Duplex-Doppler examination, performed by 
an experienced operator, is an invaluable tool for 
the diagnosis and follow-up of a stenosis [17]. 
Magnetic resonance imaging (MRI) can be 
considered a safe and non-invasive alternative to 
angiography [18]. 
The low incidence of renal artery stenosis in adult 
 and pediatrics (0.3 % and 0.4%) in our serious and 
in our previous report 0.4 % [3], though we used the 
internal iliac artery in arterial anastmosis in large 
proportion of our patients, could be attributed to the 
wide spatulation we made in both graft and internal 
iliac arteries, the procedure was done by highly 
specialized surgeons under strict supervision of the 
whole cohort of patients by single surgeon (G.M.A.) 
A stenosis could be treated conservatively or by 
revascularization. Revascularization can be surgical 
or by percutaneous transluminal renal angioplasty 
(PTRA) [15,19]. Surgical correction of graft renal 
artery stenosis is usually successful, but it is 
associated with substantial morbidity [19]. Primary 
treatment of graft renal artery stenosis by means of 
percutaneous transluminal angioplasty with or 
without stent placement results in good 
intermediate-term patency and is associated with 
significant early improvement in blood pressure and 
creatinine level [20]. Because of its low level of 
morbidity, relatively modest cost, and effectiveness, 
percutaneous transluminal angioplasty is accepted 
as the initial treatment of choice [20].  
Although early bleeding from either the arterial or 
the venous anastomosis is rare, it is not unusual for 
end-stage renal disease patients to display a 
bleeding diathesis caused by defective coagulation 
due to platelet dysfunction or altered intravascular 
coagulation.. Hemorrhage within the first week can 
occur due to graft rupture from an uncontrolled 
accelerated rejection process. After one month post-
transplant, the most common cause of hemorrhage 
is mycotic infection of the anastomosis [21]. 
There is slight but not statistically significant 
increase the hemorrhagic complications  in pediatric 
(2.5 % ) than adult (1.8 %) .this is lower than 3.86% 
reported by kocak et al 2004, this may be attributed 
to the routine heparinization of pediatric and high 
risk adult groups which may increase the risk of 
bleeding [22]. 
Contrary to the belief that pediatric transplantation 
is associated with higher morbidity, our results 
denied this believe, moreover the thrombotic 
complication is lower than that of adults. There is a 
steady decrease in vascular complications over the 
three decades inspite of training of one urologist 




There is no increased incidence of vascular 
complications in pediatrics than adult transplants. 
The vascular complications significantly adverse 
patient and graft survival in both pediatrics and 
adults renal transplants. The survival of either graft 
or patient is comparable between adult an pediatric 
with or without vascular complications and the 
subgroups of vascular complications. The 
thrombotic, stenotic and hemorrhagic events have 
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